Overview
The fund is managed with an indexed method and is distinguished by broad diversification, low tracking errors, and low-cost management.
The investment objective is to replicate the reference index as closely as possible and to minimize performance deviations from the benchmark.
The MSCI Europe ex EMU Index captures large and mid cap representation in European Developed Markets countries (excluding those in the EMU and Switzerland).
The index covers approximately 85% of the free floatadjusted market capitalization in the European ex EMU ex Switzerland equity universe.
The fund is passively managed.
Benefits
Easy access to a broadly diversified portfolio of European Equities.
Provides access to the performance of the index with a single transaction.
The fund is transparent and cost-effective and is liquid under normal market conditions.
You do not pay any federal stamp duty.
Risks
Features
| Product category |
Equity Europe |
| Product domicile |
Switzerland
|
| Portfolio management |
麻豆社 Asset Management Switzerland AG, Zurich
|
| Fund management |
麻豆社 Fund Management (Switzerland) AG
|
| Custodian bank |
麻豆社 Switzerland AG, Zurich
|
| Day of inception |
July 17, 2007
|
| Currency of account |
CHF
|
| Close of financial year |
February 28
|
| SFDR Classification |
n.a.
|
| Issue / redemption |
daily
|
| Distribution |
Reinvestment
|
| Maturity |
Open end
|
| Ongoing costs p.a. |
0.01% p.a.
|
| Flat fee |
0.00% p.a.
|
| Management fee |
0.00% p.a.
|
| Total expense ratio (TER) |
0.01% p.a.
|
| Minimum investment |
n.a.
|
| Reference Index / Benchmark |
MSCI Europe ex EMU ex Switzerland (NR) in CHF
|
| Cut-Off Time |
14:00h(CET)
|
| Securities no. |
3084956
|
| ISIN |
CH0030849563
|
| Bloomberg Ticker |
CSIFEEZ SW
|
| Reuters Id |
3084956X.CHE
|
Performance and Prices
Percentage growth
as of May 29, 2026| CHF(%) | EUR(%) | USD(%) | |
| YTD | 3.94 | 6.07 | 5.39 |
| 1M | |||
| 3M | |||
| 6M | |||
| 1Y | |||
| 2Y | 12.66 | 13.62 | 28.87 |
| 3Y | |||
| 5Y | 33.66 | 60.72 | 53.96 |
| ø p.a.5Y | 5.97 | 9.95 | 9.01 |
Current data
| Net asset value | 29.05.2026 | CHF 835.06 |
| High - last 12 months | 17.04.2026 | CHF 859.58 |
| Low - last 12 months | 02.07.2025 | CHF 728.17 |
| Assets of the unit class in mn | 29.05.2026 | CHF 924.38 |
| Total product assets in mn | 29.05.2026 | CHF 960.12 |
|
Date
|
2 years
|
5 years
|
|
| Total risk reference index / benchmark | 30.04.2026 | 9.63% | 12.17% |
| Sharpe Ratio | 30.04.2026 | 0.62 | 0.51 |
| Risk Free Rate | 30.04.2026 | 0.40% | 0.41% |
Structures
By the 10 largest positions (in %, as of April 30, 2026)
|
|
|
| HSBC Holdings PLC | 7.01 |
| AstraZeneca PLC | 6.54 |
| Shell PLC | 5.73 |
| Novo Nordisk A/S | 3.06 |
| Rolls-Royce Holdings PLC | 3.00 |
| British American Tobacco PLC | 2.84 |
| Unilever PLC | 2.83 |
| BP PLC | 2.78 |
| Rio Tinto PLC | 2.51 |
| GSK PLC | 2.38 |
Fees
Distributions
Sales Authorisations
Literature
|
Document type
|
Document Language
|
|||
| Prospectus |
|
|
||
| Key Information Document |
|
|
|
|
| Past performance |
|
|
|
|
| Previous performance scenario |
|
|
|
|
|
Document type
|
Document Language
|
|
| Annual report |
|
|
| Semi-annual report |
|
|